Annual report [Section 13 and 15(d), not S-K Item 405]

Other current assets

v3.25.1
Other current assets
12 Months Ended
Dec. 31, 2024
Other current assets  
Other current assets

Note 5 — Other current assets

Other current assets consisted of the following (in thousands):

December 31, 

December 31, 

    

2024

2023

Research and development credits receivable

 

$

12,929

$

46,098

Prepayments

 

10,033

9,954

Clinical materials

 

59

1,329

VAT receivable

1,599

Other current assets

 

3,170

2,412

$

27,790

$

59,793

The Research and development credits receivable as of December 31, 2023 includes amounts receivable for claims covering the years ended December 31, 2023 and 2022 whereas the Research and development credits receivable as of December 31, 2024 primarily relates to the claim for the year ended December 31, 2024.